Literature DB >> 22546569

Better prevention of stroke through screening for atrial fibrillation.

Martin A James, John L Campbell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22546569      PMCID： PMC3338029          DOI： 10.3399/bjgp12X641294

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  10 in total

1.  RCPE UK Consensus Conference on 'Approaching the comprehensive management of atrial fibrillation: evolution or revolution?'.

Authors:  D J Stott; R I Dewar; C J Garratt; K E Griffith; N J Harding; M A James; D A Lane; D R Petty; P A Smith; M H Somerville; J Trueland
Journal:  J R Coll Physicians Edinb       Date:  2012

2.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

Authors:  A John Camm; Paulus Kirchhof; Gregory Y H Lip; Ulrich Schotten; Irene Savelieva; Sabine Ernst; Isabelle C Van Gelder; Nawwar Al-Attar; Gerhard Hindricks; Bernard Prendergast; Hein Heidbuchel; Ottavio Alfieri; Annalisa Angelini; Dan Atar; Paolo Colonna; Raffaele De Caterina; Johan De Sutter; Andreas Goette; Bulent Gorenek; Magnus Heldal; Stefan H Hohloser; Philippe Kolh; Jean-Yves Le Heuzey; Piotr Ponikowski; Frans H Rutten
Journal:  Europace       Date:  2010-10       Impact factor: 5.214

3.  A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.

Authors:  F D R Hobbs; D A Fitzmaurice; J Mant; E Murray; S Jowett; S Bryan; J Raftery; M Davies; G Lip
Journal:  Health Technol Assess       Date:  2005-10       Impact factor: 4.014

4.  [Principles and practice of mass screening for disease].

Authors:  J M Wilson; Y G Jungner
Journal:  Bol Oficina Sanit Panam       Date:  1968-10

5.  Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls.

Authors:  M Man-Son-Hing; G Nichol; A Lau; A Laupacis
Journal:  Arch Intern Med       Date:  1999-04-12

6.  Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial.

Authors:  M R Frankel; L B Morgenstern; T Kwiatkowski; M Lu; B C Tilley; J P Broderick; R Libman; S R Levine; T Brott
Journal:  Neurology       Date:  2000-10-10       Impact factor: 9.910

7.  Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study.

Authors:  Jonas Bjerring Olesen; Gregory Y H Lip; Jesper Lindhardsen; Deirdre A Lane; Ole Ahlehoff; Morten Lock Hansen; Jakob Raunsø; Janne Schurmann Tolstrup; Peter Riis Hansen; Gunnar Hilmar Gislason; Christian Torp-Pedersen
Journal:  Thromb Haemost       Date:  2011-07-20       Impact factor: 5.249

8.  Apixaban in patients with atrial fibrillation.

Authors:  Stuart J Connolly; John Eikelboom; Campbell Joyner; Hans-Christoph Diener; Robert Hart; Sergey Golitsyn; Greg Flaker; Alvaro Avezum; Stefan H Hohnloser; Rafael Diaz; Mario Talajic; Jun Zhu; Prem Pais; Andrzej Budaj; Alexander Parkhomenko; Petr Jansky; Patrick Commerford; Ru San Tan; Kui-Hian Sim; Basil S Lewis; Walter Van Mieghem; Gregory Y H Lip; Jae Hyung Kim; Fernando Lanas-Zanetti; Antonio Gonzalez-Hermosillo; Antonio L Dans; Muhammad Munawar; Martin O'Donnell; John Lawrence; Gayle Lewis; Rizwan Afzal; Salim Yusuf
Journal:  N Engl J Med       Date:  2011-02-10       Impact factor: 91.245

9.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Authors:  Gregory Y H Lip; Robby Nieuwlaat; Ron Pisters; Deirdre A Lane; Harry J G M Crijns
Journal:  Chest       Date:  2009-09-17       Impact factor: 9.410

10.  Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.

Authors:  Jonathan Mant; F D Richard Hobbs; Kate Fletcher; Andrea Roalfe; David Fitzmaurice; Gregory Y H Lip; Ellen Murray
Journal:  Lancet       Date:  2007-08-11       Impact factor: 79.321
  10 in total
  1 in total

1.  Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey.

Authors:  Tim A Holt; Tina D Hunter; Candace Gunnarsson; Nada Khan; Paul Cload; Gregory Y H Lip
Journal:  Br J Gen Pract       Date:  2012-10       Impact factor: 5.386
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.